Related references
Note: Only part of the references are listed.An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia
Jeff Sharman et al.
BLOOD (2015)
Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
Madeleine Duvic et al.
BLOOD (2015)
Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation
Larisa J. Geskin et al.
BLOOD (2015)
Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma
Yun-Wen Chen et al.
BLOOD (2015)
HDAC inhibition prevents white matter injury by modulating microglia/macrophage polarization through the GSK3β/PTEN/Akt axis
Guohua Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
T-cell lymphoma: Microenvironment-related biomarkers
Eric Tse et al.
SEMINARS IN CANCER BIOLOGY (2015)
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Can Kucuk et al.
NATURE COMMUNICATIONS (2015)
The signaling symphony: T cell receptor tunes cytokine-mediated T cell differentiation
Weishan Huang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Personalized treatment of Sezary syndrome by targeting a novel CTLA4: CD28 fusion
Aleksandar Sekulic et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2015)
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma
Oreofe Odejide et al.
BLOOD (2014)
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
Mark J. Kiel et al.
BLOOD (2014)
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features
Tianjiao Wang et al.
BLOOD (2014)
Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels
Celine Bossard et al.
BLOOD (2014)
Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin
Steven M. Horwitz et al.
BLOOD (2014)
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Javeed Iqbal et al.
BLOOD (2014)
A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders
Thirunavukkarasu Velusamy et al.
BLOOD (2014)
Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression
Elena Netchiporouk et al.
CELL CYCLE (2014)
PI3K/mTOR Inhibition Markedly Potentiates HDAC Inhibitor Activity in NHL Cells through BIM- and MCL-1-Dependent Mechanisms In Vitro and In Vivo
Mohamed Rahmani et al.
CLINICAL CANCER RESEARCH (2014)
Recurrent Mutation of JAK3 in T-Cell Prolymphocytic Leukemia
Anke K. Bergmann et al.
GENES CHROMOSOMES & CANCER (2014)
Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma
Masao Nakagawa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Premature Terminal Differentiation Protects from Deregulated Lymphocyte Activation by ITK-Syk
Martina P. Bach et al.
JOURNAL OF IMMUNOLOGY (2014)
Cutaneous T Cell Lymphoma Expresses Immunosuppressive CD80 (B7-1) Cell Surface Protein in a STAT5-Dependent Manner
Qian Zhang et al.
JOURNAL OF IMMUNOLOGY (2014)
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway
P. P. Piccaluga et al.
LEUKEMIA (2014)
A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma
Hae Yong Yoo et al.
NATURE GENETICS (2014)
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma
Mamiko Sakata-Yanagimoto et al.
NATURE GENETICS (2014)
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
Teresa Palomero et al.
NATURE GENETICS (2014)
The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas
R. Briski et al.
BLOOD CANCER JOURNAL (2014)
Signaling by the Phosphoinositide 3-Kinase Family in Immune Cells
Klaus Okkenhaug
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes
Michael J. Clemente et al.
BLOOD (2013)
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
Jason A. Dubovsky et al.
BLOOD (2013)
Hydrochlorothiazide and Cutaneous T Cell Lymphoma Prospective Analysis and Case Series
Richard R. Jahan-Tigh et al.
CANCER (2013)
Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas
Esperanza Martin-Sanchez et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2013)
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features
Bettina Bisig et al.
HAEMATOLOGICA (2013)
Signaling of the ITK (Interleukin 2-inducible T Cell Kinase)-SYK (Spleen Tyrosine Kinase) Fusion Kinase Is Dependent on Adapter SLP-76 and on the Adapter Function of the Kinases SYK and ZAP70
Alamdar Hussain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Modulation of T cell signaling by the actin cytoskeleton
Yan Yu et al.
JOURNAL OF CELL SCIENCE (2013)
Phosphatidylinositol 3-Kinase-Independent Signaling Pathways Contribute to ICOS-Mediated T Cell Costimulation in Acute Graft-Versus-Host Disease in Mice
Jun Li et al.
JOURNAL OF IMMUNOLOGY (2013)
Clinical targeting of the TNF and TNFR superfamilies
Michael Croft et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Inhibitors of BTK and ITK: State of the New Drugs for Cancer, Autoimmunity and Inflammatory Diseases
L. Vargas et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2013)
Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas
S. M. Rodriguez-Pinilla et al.
BLOOD CANCER JOURNAL (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
T cell receptor signalling networks: branched, diversified and bounded
Rebecca J. Brownlie et al.
NATURE REVIEWS IMMUNOLOGY (2013)
CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications
Matthew W. Anderson et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
David A. Hume et al.
BLOOD (2012)
STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia
Andres Jerez et al.
BLOOD (2012)
How I treat enteropathy-associated T-cell lymphoma
Antonio Di Sabatino et al.
BLOOD (2012)
STATs Shape the Active Enhancer Landscape of T Cell Populations
Golnaz Vahedi et al.
CELL (2012)
The B7 Homologues and their Receptors in Hematologic Malignancies
Ryan A. Wilcox et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Autocrine IL-21 Stimulation Is Involved in the Maintenance of Constitutive STAT3 Activation in Sezary Syndrome
Leslie van der Fits et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas
Daniela Laimer et al.
NATURE MEDICINE (2012)
Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management
Ryan A. Wilcox
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Follicular Helper CD4 T Cells (T-FH)
Shane Crotty
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP
Wei Ju et al.
BLOOD (2011)
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
Andrew L. Feldman et al.
BLOOD (2011)
Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS
Qian Zhang et al.
BLOOD (2011)
FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma
Natalina E. Elliott et al.
BLOOD (2011)
The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma
Ronnie M. Abraham et al.
CANCER BIOLOGY & THERAPY (2011)
ICOS Receptor Instructs T Follicular Helper Cell versus Effector Cell Differentiation via Induction of the Transcriptional Repressor BcI6
Youn Soo Choi et al.
IMMUNITY (2011)
TCR-dependent transformation of mature memory phenotype T cells in mice
Xi Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma
Christiane Querfeld et al.
LEUKEMIA & LYMPHOMA (2011)
Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells
Takanori So et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Itk Controls the Spatiotemporal Organization of T Cell Activation
Kentner L. Singleton et al.
SCIENCE SIGNALING (2011)
Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
Michael Croft
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia
Jing Chen et al.
BLOOD (2010)
The ITK-SYK Fusion Oncogene Induces a T-Cell Lymphoproliferative Disease in Mice Mimicking Human Disease
Christine Dierks et al.
CANCER RESEARCH (2010)
Transcriptional Profiles Predict Disease Outcome in Patients with Cutaneous T-Cell Lymphoma
Ivan V. Litvinov et al.
CLINICAL CANCER RESEARCH (2010)
Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations
Eva Geissinger et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma
Konstanze Pechloff et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Phosphoinositide 3-Kinase Activity in T Cells Regulates the Magnitude of the Germinal Center Reaction
Julia Rolf et al.
JOURNAL OF IMMUNOLOGY (2010)
Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines
R. A. Wilcox et al.
LEUKEMIA (2010)
T-cell receptor-driven lymphomagenesis in mice derived from a reprogrammed T cell
Thomas Serwold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
T-Cell Signaling Regulated by the Tec Family Kinase, Itk
Amy H. Andreotti et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
An Enigmatic Tail of CD28 Signaling
Jonathan S. Boomer et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells
Ryan A. Wilcox et al.
BLOOD (2009)
Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition
Stefanie Bug et al.
CANCER GENETICS AND CYTOGENETICS (2009)
FOXP3+CD25- Tumor Cells with Regulatory Function in Sezary Syndrome
Julia B. Heid et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase
Mathieu Gigoux et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
ICOS ligation recruits the p50α PI3K regulatory subunit to the immunological synapse
Camille Fos et al.
JOURNAL OF IMMUNOLOGY (2008)
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas
A. L. Feldman et al.
LEUKEMIA (2008)
T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus
T. J. Hagenbeek et al.
LEUKEMIA (2008)
The selective protein kinase C β inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway
Christiane Querfeld et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
An APRIL to remember: novel TNF ligands as therapeutic targets
SR Dillon et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma
B Streubel et al.
LEUKEMIA (2006)
Expression of platelet-derived growth factor receptor α in peripheral T-cell lymphoma not otherwise specified
PP Piccaluga et al.
LANCET ONCOLOGY (2005)
Polycomb group protein Ezh2 controls actin polymerization and cell signaling
I Su et al.
CELL (2005)
Evidence for restricted Vβ usage in the leukemic phase of cutaneous T cell lymphoma
EC Vonderheid et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Signaling through ltk promotes T helper 2 differentiation via negative regulation of T-bet
AT Miller et al.
IMMUNITY (2004)
Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL
T Tsuchiya et al.
BLOOD (2004)
Differential expression of T-bet, a T-box transcription factor required for Th1 T-cell development, in peripheral T-cell lymphomas
DM Dorfman et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR)
A Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
